Subject(s)
DNA/analysis , Fluorometry/instrumentation , Sequence Analysis, DNA/instrumentation , Automation , DNA Primers , DNA, Bacterial/analysis , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Deoxyribonucleotides/chemistry , Electrophoresis, Polyacrylamide Gel/instrumentation , Electrophoresis, Polyacrylamide Gel/methods , Equipment Design , Equipment Failure , Escherichia coli/genetics , Fluorescent Dyes/analysis , Fluorometry/methods , Indicators and Reagents , Ion Exchange Resins , Nucleic Acid Denaturation , Point Mutation , Polymerase Chain Reaction , Sequence Analysis, DNA/methods , Silicon Dioxide , Software , Specimen Handling , Taq Polymerase/genetics , Taq Polymerase/metabolism , Templates, Genetic , Urea/pharmacologySubject(s)
DNA/analysis , Fluorometry/instrumentation , Sequence Analysis, DNA/instrumentation , Automation , Calibration , DNA Primers , Equipment Design , Equipment Failure , Fluorescent Dyes/analysis , Fluorometry/methods , Humans , Indicators and Reagents , Polymerase Chain Reaction , Sequence Analysis, DNA/methods , Software , Specimen Handling , Templates, GeneticABSTRACT
Type VIII collagen is a short-chain collagen with considerable similarity to type X collagen. We have generated chain-specific antibodies to the alpha 1 and alpha 2 chains of type VIII collagen, and used them as probes to examine the synthesis of type VIII collagen by vascular smooth muscle cells (VSMC). In addition, chain-specific oligonucleotides have been used in reverse transcriptase-PCR (RT-PCR) reactions with RNA extracted from cultured smooth muscle cells in culture and from freshly isolated vascular tissues. Radiolabelling of VSMC in culture and immunoprecipitation with chain-specific antibodies showed that both chains were expressed. Lower levels of type VIII collagen were found in adult VSMC than in neonatal VSMC. RT-PCR showed that both chains were expressed in tissues as well as cells in culture. The results indicate that type VIII collagen is a product of VSMC of normal adult vessels and is expressed at high levels by VSMC in vascular lesions.
Subject(s)
Collagen/biosynthesis , Muscle, Smooth, Vascular/metabolism , Adult , Amino Acid Sequence , Animals , Aorta/metabolism , Base Sequence , Cattle , Cells, Cultured , DNA Primers , Fetus , Humans , Infant , Intestinal Mucosa/enzymology , Oligonucleotides, Antisense , Pepsin A/metabolism , Polymerase Chain Reaction , Sudden Infant Death , SwineSubject(s)
Collagen/chemistry , Animals , Cloning, Molecular , Collagen/biosynthesis , Collagen/genetics , DNA, Complementary/genetics , Humans , In Vitro Techniques , Molecular Structure , Protein Biosynthesis , Protein Conformation , Rabbits , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/geneticsABSTRACT
Tyrosine-rich acidic matrix protein (TRAMP; 22 kDa extracellular matrix protein; dermatopontin) is a protein that co-purifies with lysyl oxidase and with dermatan sulphate proteoglycans, with possible functions in cell-matrix interactions and matrix assembly. Using a rabbit polyclonal antiserum raised against porcine TRAMP, which cross-reacts with both the human and murine forms of the protein, we show by immunoblotting that TRAMP has a widespread tissue distribution, including skin, skeletal muscle, heart, lung, kidney, cartilage and bone. In cultures of human skin fibroblasts, TRAMP incorporates both [35S]sulphate and [3H]tyrosine and is secreted into the medium, as shown by immunoprecipitation. Amino acid analysis of immunoprecipitated TRAMP demonstrates that many of the tyrosine residues in TRAMP are sulphated.
Subject(s)
Chondroitin Sulfate Proteoglycans/metabolism , Extracellular Matrix Proteins/metabolism , Tyrosine/metabolism , Animals , Blotting, Western , Cells, Cultured , Chondroitin Sulfate Proteoglycans/biosynthesis , Chromatography, High Pressure Liquid , Cross Reactions , Electrophoresis, Polyacrylamide Gel , Extracellular Matrix Proteins/biosynthesis , Humans , Mice , Mice, Inbred C57BL , Precipitin Tests , Sulfuric Acids/metabolism , SwineABSTRACT
Tyrosine-rich acidic matrix protein (TRAMP) is a recently discovered protein that co-purifies with porcine skin lysyl oxidase and is equivalent to the M(r) 22,000 extracellular matrix protein from bovine skin that co-purifies with dermatan sulfate proteoglycans (Cronshaw, A. D., MacBeath, J. R. E., Shackleton, D. R., Collins, J. F., Fothergill-Gilmore, L. A., and Hulmes, D. J. S. (1993) Matrix 13, 255-266; Neame, P. J., Choi, H. U., and Rosenberg, L. C. (1989) J. Biol. Chem. 264, 5474-5479). The effect of TRAMP on collagen fibril formation was studied in vitro by reconstitution of fibrils from lathyritic rat skin collagen I. Fibril formation was initiated by the warm start procedure, in which acidic collagen solutions and double strength neutral buffer, both preincubated separately at 34 degrees C, were mixed. When monitored by turbidimetry, TRAMP was found to accelerate collagen fibril formation. Acceleration occurred at sub-stoichiometric molar ratios of TRAMP collagen, and the presence of TRAMP stabilized the fibrils against low temperature dissociation. It was confirmed by centrifugation that the amount of fibrillar collagen formed in the presence of TRAMP was greater than in its absence. By SDS-polyacrylamide gel electrophoresis and scanning densitometry, binding of TRAMP to collagen was detected that approached saturation with a molar ratio of TRAMP to collagen of approximately 1:2. Fibrils formed in the presence of TRAMP were normal when observed by electron microscopy, although fibril diameters were smaller than the controls. TRAMP was found to partially reverse the inhibitory effects of urea and increased ionic strength on the kinetics of fibril formation, although inhibition by glucose was unaffected. TRAMP also accelerated the assembly of pepsin-treated collagen, where the non-helical, telopeptide regions were partially removed. Acceleration of collagen fibril formation by TRAMP is discussed in the light of the known effects of other extracellular matrix components on this process.
Subject(s)
Chondroitin Sulfate Proteoglycans/metabolism , Collagen/metabolism , Collagen/ultrastructure , Extracellular Matrix Proteins/metabolism , Skin/metabolism , Animals , Chondroitin Sulfate Proteoglycans/isolation & purification , Collagen/isolation & purification , Electrophoresis, Disc , Extracellular Matrix Proteins/isolation & purification , Kinetics , Lathyrism/metabolism , Male , Microscopy, Electron , Nephelometry and Turbidimetry , Protein-Lysine 6-Oxidase/isolation & purification , Rats , Rats, Sprague-DawleyABSTRACT
A protein (M(r)24 K) that co-purifies with porcine skin lysyl oxidase (M(r)34 K) has been isolated and characterised. Five variants of the 24 K protein were identified by Mono Q ion-exchange FPLC, as were four variants of lysyl oxidase. Amino acid analysis and partial sequencing revealed near identity of a 36-residue CNBr peptide from porcine skin lysyl oxidase to corresponding regions of the putative lysyl oxidase precursor derived from rat and human cDNA. The 24 K protein was found to be unrelated to lysyl oxidase, but comparison with a protein sequence database showed it to be the same as a recently described protein from bovine skin that is associated with dermatan sulphate proteoglycans. The 24 K protein is relatively rich in tyrosine, and isoelectric focussing shows it to be acidic, with pI's in the range 4.1 to 4.4. In view of these properties, we propose the name TRAMP (Tyrosine Rich Acidic Matrix Protein) to identify this protein. Though TRAMP appears not to be glycosylated, several experiments indicate the presence of sulphotyrosine residues. When assayed using an elastin substrate, the activity of lysyl oxidase is unaffected by TRAMP.